NSEAnalysts/Institutional Investor Meet/Con. Call Updates6d ago · 15 Jul 2026, 07:25 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Anthem Biosciences Limited · ANTHEM
✦ AI SummaryResults
Anthem Biosciences Limited has scheduled an earnings conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Anthem Biosciences Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
COMPLIANCE_ABL1_15072026192457_InvestorCallIntimationQ1Signed.pdf
View document text
Date: July 15, 2026
BSE Limited, National Stock Exchange of India Limited
20th Floor, P.J. Towers, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai - 400001. Bandra Kurla Complex,
BSE Scrip Code: 544449 Bandra (E), Mumbai – 400 051
NSE Scrip Symbol: ANTHEM
Subject: Intimation of Schedule of Earnings Conference Call under Regulation 30 of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/Ma’am
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings
Conference Call to discuss the Unaudited Standalone and Consolidated Financial Results of the Company
for the quarter ended June 30, 2026, is scheduled on Wednesday, July 22, 2026 at 11:30 AM IST.
The details pertaining to the said call are enclosed herewith and the same will also be available on the
Company’s website at https://anthembio.com/
We request you to kindly take the same on record.
Thanking you,
Yours truly,
For Anthem Biosciences Limited
(Formerly known as Anthem Biosciences Private Limited)
Divya Prasad
Company Secretary & Compliance Officer
Membership No: A41438
OPTION 1 | Diamond Pass
Pre-registration link: CLICK HERE
The Management of
OPTION 2 | Dial-in through Operator Assistance
Anthem Biosciences Limited
invites you to the
ACCESS NUMBERS
Q1 FY27 Earnings
+91 22 6280 1102
Universal Access Numbers
Conference Call +91 22 7115 8003
The numbers listed above are universally accessible from all networks and all countries.
To discuss the performance for the quarter ended June 30, 2026
INTERNATIONAL TOLL FREE NUMBERS
USA 186674 62133
DAY / DATE TIME
Wednesday, 22nd July, 2026 11:30 am IST UK 080810 11573
Hong Kong 80096 4448
Singapore 80010 12045
MA N A G E ME N T PA R T I C I PAN T S
Mr. Ajay Bhardwaj Mr. Gawir Baig
Managing Director & CEO Chief Financial Officer
Participants are requested to dial-in 5 minutes in advance
For more information: Adfactors PR (Investor Relations)
Forum Goshar: +91 7045646599 | Email: anthem@adfactorspr.com